Neurogene Inc.
NGNE · NASDAQ
Bulios Fair Price
$16.36
49.0% downside
Trenutna cena
$32.09
Po podatkih Bulios Fair Price je delnica NGNE trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
O podjetju
Neurogene Inc. is an American biopharmaceutical company focused on the development of innovative therapies for the treatment of genetic neurological disorders. The company specializes in researching and developing gene therapy-based drugs that have the potential to treat and improve the lives of patients with genetically inherited neurological disorders.
V vašem jeziku še ni na voljo, zato je besedilo v angleščini.
Sector
Healthcare
Industry
Biotechnology
CEO
Rachel L. McMinn
Employees
131
Headquarters
New York City
Prihajajoči dogodki
Earnings
Upcoming earnings report